The Promoting Effect of Radiation on Glucose Metabolism in Breast Cancer Cells under the Treatment of Cobalt Chloride (Q38762365)

6 September 2017

title

The Promoting Effect of Radiation on Glucose Metabolism in Breast Cancer Cells under the Treatment of Cobalt Chloride (English)

1 reference

6 September 2017

Chun-Bo Zhao

1

1 reference

6 September 2017

Lei Shi

series ordinal

2

1 reference

6 September 2017

Hai-Hong Pu

series ordinal

3

1 reference

6 September 2017

Qing-Yuan Zhang

series ordinal

4

1 reference

6 September 2017

publication date

24 June 2016

1 reference

Pathology and Oncology Research

6 September 2017

published in

1 reference

6 September 2017

volume

23

1 reference

6 September 2017

issue

1

1 reference

6 September 2017

page(s)

47-53

1 reference

6 September 2017

cites work

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Tumor hypoxia and malignant progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Molecular imaging of hypoxia with radiolabelled agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Hypoxia and hypoxia inducible factors in tumor metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Why do cancers have high aerobic glycolysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Theoretical simulation of tumour oxygenation and results from acute and chronic hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Investigating hypoxic tumor physiology through gene expression patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Hypoxia signalling controls metabolic demand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Oxygen sensing, homeostasis, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Metabolic targeting of hypoxia and HIF1 in solid tumors can enhance cytotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Recent agents targeting HIF-1α for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Cetuximab reverses the Warburg effect by inhibiting HIF-1-regulated LDH-A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Mitochondrial reactive oxygen species trigger hypoxia-induced transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Stabilization of wild-type p53 by hypoxia-inducible factor 1α

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Mitochondrial DNA damage and a hypoxic response are induced by CoCl(2) in rat neuronal PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Oxygen levels do not determine radiation survival of breast cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

The hypoxic tumour microenvironment, patient selection and hypoxia-modifying treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

The anti-oxidant capacity of tumour glycolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Dual control of glut1 glucose transporter gene expression by hypoxia and by inhibition of oxidative phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1α

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

IDH1 and IDH2 mutations in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Quantitative analysis of energy metabolic pathways in MCF-7 breast cancer cells by selected reaction monitoring assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

Targeting metabolic transformation for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12253-016-0076-3

BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27342248

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Hypoxia-driven angiogenesis: role of tip cells and extracellular matrix scaffolding.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27342248

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Signaling in control of cell growth and metabolism

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27342248

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12253-016-0076-3

1 reference

6 September 2017

1 reference